Journal article
Anti-inflammatory actions of Pentosan polysulfate sodium in a mouse model of influenza virus A/PR8/34-induced pulmonary inflammation
R Krishnan, CJM Stapledon, H Mostafavi, JR Freitas, X Liu, S Mahalingam, A Zaid
Frontiers in Immunology | Published : 2023
Abstract
Introduction: There is an unmet medical need for effective anti-inflammatory agents for the treatment of acute and post-acute lung inflammation caused by respiratory viruses. The semi-synthetic polysaccharide, Pentosan polysulfate sodium (PPS), an inhibitor of NF-kB activation, was investigated for its systemic and local anti-inflammatory effects in a mouse model of influenza virus A/PR8/1934 (PR8 strain) mediated infection. Methods: Immunocompetent C57BL/6J mice were infected intranasally with a sublethal dose of PR8 and treated subcutaneously with 3 or 6 mg/kg PPS or vehicle. Disease was monitored and tissues were collected at the acute (8 days post-infection; dpi) or post-acute (21 dpi) p..
View full abstractGrants
Funding Acknowledgements
This study was conducted at the Menzies Health Institute Queensland, Griffith University, as a contract research project funded by Paradigm Biopharmaceuticals Ltd (https://paradigmbiopharma.com/). The funders did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript beyond those specified.